Inozyme Pharma Inc. (INZY) Social Stream



Inozyme Pharma Inc. (INZY): $2.99

0.18 (+6.41%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add INZY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#177 of 334

in industry

Featured Post From StockTwits About INZY

$INZY New SEC Filing: 8-K Earnings - Inozyme Pharma, Inc. (0001693011) August 11


Item 2.02 Results of Operations and Financial Condition. On August 11, 2021, Inozyme Pharma, Inc. (the "Company") announced its financial results for the quarter ended June 30, 2021. The full text of the press release issued in connection with the announcement is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made (...)

https://mkn.re/94252
MarketNewswire, published August 11, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!